Technology
Health
Biotechnology

Prothena

$12.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.00 (-7.52%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Prothena and other stocks, options, ETFs, and crypto commission-free!

About

Prothena Corporation plc Ordinary Shares, also called Prothena, is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. Read More The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Employees
59
Headquarters
Dun Laoghaire, Dublin
Founded
1969
Market Cap
490.32M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
600.29K
High Today
$13.28
Low Today
$12.25
Open Price
$13.23
Volume
148.93K
52 Week High
$44.75
52 Week Low
$8.63

Collections

Technology
Health
Biotechnology
Medical
Europe (Non-UK)
Europe

News

Guru FocusMar 15

Prothena Corp PLC (PRTA) Files 10-K for the Fiscal Year Ended on December 31, 2018

Prothena Corp PLC (NASDAQ:PRTA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Prothena Corp PLC is a biotechnology company.

12
MarketBeatMar 2

Stock Price, News, & Analysis for Prothena

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel immunotherapies for the treatment of diseases in the neuroscience and orphan categories.

5

Earnings

-$1.48
-$1.14
-$0.80
-$0.46
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.